$AZN +3% Farxgiga approved in US for CKD. source
$BCRX -4% Orladeyo EU approval for hereditary angioedema. source
$PRAX -5% PRAX-562 receives Orphan Drug designation for treatment of SCN2A-DEE. source
$SCYX +3% Ph 3 data presented at ACOG conference. source